Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Siqing Fu

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-1933-0419; OpenAlex author ID A5045197829.

Their work

Papers
1
Trials
3 (principal investigator on 3)
Grants
0
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 trial · 2020: none · 2021: none · 2022: 1 trial · 2023: none · 2024: 1 trial

Papers 1

  1. Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗

Trials 3

  1. Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epith… Principal investigator NCT06576037↗
  2. Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors Principal investigator NCT05431582↗
  3. A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors Principal investigator NCT03784677↗

Closest collaborators

The 13 strongest of 13 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Funda Meric-Bernstam · 1 shared paper, 2017
  2. Milind M. Javle · 1 shared paper, 2017
  3. Sarina Anne Piha-Paul · 1 shared paper, 2017
  4. Jennifer Brooke Goldstein · 1 shared paper, 2017
  5. David R. Fogelman · 1 shared paper, 2017
  6. Aung Naing Pe · 1 shared paper, 2017
  7. Chad Z. Tang · 1 shared paper, 2017
  8. Robert A. Wolff · 1 shared paper, 2017
  9. Kenneth R. Hess · 1 shared paper, 2017
  10. Apostolia Maria Tsimberidou · 1 shared paper, 2017
  11. Gauri Rajani Varadhachary · 1 shared paper, 2017
  12. Vivek Subbiah · 1 shared paper, 2017
  13. David S. Hong · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.